T1	Disease 54 88	CAH-associated adrenal myelolipoma
#1	AnnotatorNotes T1	not found
T11	Biomarker 370 432	compound heterozygous mutation (c.293-13C>G/c.518T>A, p.I173N)
T16	Disease 476 511	CAH-associated adrenal myelolipomas
T17	Chemical 523 528	17-OH
T18	Disease 523 539	17-OH deficiency
T19	Biomarker 557 640	compound heterozygous mutation (c.1118A>T, p.H373L/c.1459_1467del9, p.D487_F489del)
T2	Chemical 147 152	21-OH
T25	Disease 706 709	CAH
#8	AnnotatorNotes T25	DOID:0050811
T26	Disease 759 778	adrenal myelolipoma
#9	AnnotatorNotes T26	not found
T27	Disease 1026 1046	adrenal myelolipomas
#10	AnnotatorNotes T27	DOID:656
T3	Biomarker 147 163	21-OH deficiency
T4	Chemical 198 203	17-OH
T5	Biomarker 198 214	17-OH deficiency
T7	Disease 286 327	CAH-associated giant adrenal myelolipomas
#15	AnnotatorNotes T7	not found
T8	Chemical 341 346	21-OH
T9	Disease 341 357	21-OH deficiency
R1	Association Arg1:T3 Arg2:T1	
R2	Association Arg1:T5 Arg2:T1	
T6	Collection 341 432	21-OH deficiency caused by a compound heterozygous mutation (c.293-13C>G/c.518T>A, p.I173N)
R3	Risk-Factor Arg1:T6 Arg2:T9	
T10	Collection 523 639	17-OH deficiency resulting from a compound heterozygous mutation (c.1118A>T, p.H373L/c.1459_1467del9, p.D487_F489del
R4	Risk-Factor Arg1:T10 Arg2:T18	
T12	Biomarker 933 1011	compound heterozygous mutations, but not the single mutation, in the CYP genes
R5	Association Arg1:T12 Arg2:T27	
T13	GeneFamily 1002 1005	CYP
#2	AnnotatorNotes T13	family:862
#3	AnnotatorNotes T9	not found
#4	AnnotatorNotes T18	not found
